- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Human Reproductive Technologies industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Teva Pharmaceutical Industries Ltd
Johnson & Johnson
Pfizer Inc
Reckitt Benckiser Group plc
bbott Laboratories Inc
Merck Serono
Ferring International Center SA
Bayer AG
Church & Dwight, Co Inc
Merck & Co Inc
Actavis Inc
By Type:
Zygote Intrafallopian Transfer (ZIFT)
In Vitro Fertilization (IVF)
Intracytoplasmic Sperm Injection (ICSI)
Intrauterine Insemination (IUI)
Gamete Intrafallopian Transfer (GIFT)
Contraceptive Technology
By Application:
Hospitals
Fertility Clinics
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Human Reproductive Technologies Market Overview 2018-2029
-
1.1 China Human Reproductive Technologies Industry Development Overview
-
1.2 China Human Reproductive Technologies Industry Development History
-
1.3 China Human Reproductive Technologies Industry Market Size (2018-2029)
-
1.4 China Human Reproductive Technologies Market Analysis by Type from Production Side
-
1.4.1 China Human Reproductive Technologies Production Volume, Production Value and Growth Rate of Zygote Intrafallopian Transfer (ZIFT) (2018-2029)
-
1.4.2 China Human Reproductive Technologies Production Volume, Production Value and Growth Rate of In Vitro Fertilization (IVF) (2018-2029)
-
1.4.3 China Human Reproductive Technologies Production Volume, Production Value and Growth Rate of Intracytoplasmic Sperm Injection (ICSI) (2018-2029)
-
1.4.4 China Human Reproductive Technologies Production Volume, Production Value and Growth Rate of Intrauterine Insemination (IUI) (2018-2029)
-
1.4.5 China Human Reproductive Technologies Production Volume, Production Value and Growth Rate of Gamete Intrafallopian Transfer (GIFT) (2018-2029)
-
1.4.6 China Human Reproductive Technologies Production Volume, Production Value and Growth Rate of Contraceptive Technology (2018-2029)
-
1.5 China Human Reproductive Technologies Market Analysis by Application from Consumption End
-
1.5.1 China Human Reproductive Technologies Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)
-
1.5.2 China Human Reproductive Technologies Sales Volume, Sales Value and Growth Rate of Fertility Clinics (2018-2029)
-
1.6 China Human Reproductive Technologies Market Analysis by Region
-
1.6.1 North China Human Reproductive Technologies Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Human Reproductive Technologies Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Human Reproductive Technologies Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Human Reproductive Technologies Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Human Reproductive Technologies Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Human Reproductive Technologies Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Human Reproductive Technologies Market Size and Growth Rate from 2018-2029
Chapter 2 China Human Reproductive Technologies Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Human Reproductive Technologies Market Status and Competition at home and abroad in 2023
-
2.2.2 China Human Reproductive Technologies Market Status and Competition Analysis in 2023
-
2.2.3 China Human Reproductive Technologies Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Human Reproductive Technologies Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Human Reproductive Technologies Industry Development
Chapter 3 Human Reproductive TechnologiesIndustry Chain Analysis
-
3.1 Human Reproductive Technologies Industry Chain
-
3.2 Human Reproductive Technologies Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Human Reproductive Technologies Market
-
3.3 Human Reproductive Technologies Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Human Reproductive Technologies Market
Chapter 4 China Human Reproductive Technologies Market, by Type
-
4.1 China Human Reproductive Technologies Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Human Reproductive Technologies Total Production Volume and Growth Rate from Production Side
-
4.5 China Human Reproductive Technologies Production Volume and Growth Rate, by Type
-
4.5.1 China Human Reproductive Technologies Production Volume and Growth Rate of Zygote Intrafallopian Transfer (ZIFT)
-
4.5.2 China Human Reproductive Technologies Production Volume and Growth Rate of In Vitro Fertilization (IVF)
-
4.5.3 China Human Reproductive Technologies Production Volume and Growth Rate of Intracytoplasmic Sperm Injection (ICSI)
-
4.5.4 China Human Reproductive Technologies Production Volume and Growth Rate of Intrauterine Insemination (IUI)
-
4.5.5 China Human Reproductive Technologies Production Volume and Growth Rate of Gamete Intrafallopian Transfer (GIFT)
-
4.5.6 China Human Reproductive Technologies Production Volume and Growth Rate of Contraceptive Technology
Chapter 5 China Human Reproductive Technologies Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Human Reproductive Technologies Total Market Size and Growth Rate from Consumption End
-
5.5 China Human Reproductive Technologies Market Size and Growth Rate, by Application
-
5.5.1 China Human Reproductive Technologies Market Size and Growth Rate of Hospitals
-
5.5.2 China Human Reproductive Technologies Market Size and Growth Rate of Fertility Clinics
Chapter 6 China Human Reproductive Technologies Market, by Region
-
6.1 China Human Reproductive Technologies Production Volume and Production Value, by Region
-
6.2 China Human Reproductive Technologies Sales Volume and Sales Value, by Region
Chapter 7 North China Human Reproductive Technologies Market Analysis
-
7.1 North China Human Reproductive Technologies Market, by Type
-
7.2 North China Human Reproductive Technologies Market, by Application
Chapter 8 Central China Human Reproductive Technologies Market Analysis
-
8.1 Central China Human Reproductive Technologies Market, by Type
-
8.2 Central China Human Reproductive Technologies Market, by Application
Chapter 9 South China Human Reproductive Technologies Market Analysis
-
9.1 South China Human Reproductive Technologies Market, by Type
-
9.2 South China Human Reproductive Technologies Market, by Application
Chapter 10 East China Human Reproductive Technologies Market Analysis
-
10.1 East China Human Reproductive Technologies Market, by Type
-
10.2 East China Human Reproductive Technologies Market, by Application
Chapter 11 Northeast China Human Reproductive Technologies Market Analysis
-
11.1 Northeast China Human Reproductive Technologies Market, by Type
-
11.2 Northeast China Human Reproductive Technologies Market, by Application
Chapter 12 Southwest China Human Reproductive Technologies Market Analysis
-
12.1 Southwest China Human Reproductive Technologies Market, by Type
-
12.2 Southwest China Human Reproductive Technologies Market, by Application
Chapter 13 Northwest China Human Reproductive Technologies Market Analysis
-
13.1 Northwest China Human Reproductive Technologies Market, by Type
-
13.2 Northwest China Human Reproductive Technologies Market, by Application
Chapter 14 Company Profiles
-
14.1 Teva Pharmaceutical Industries Ltd
-
14.1.1 Teva Pharmaceutical Industries Ltd Company Profile
-
14.1.2 Teva Pharmaceutical Industries Ltd Human Reproductive Technologies Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Johnson & Johnson
-
14.2.1 Johnson & Johnson Company Profile
-
14.2.2 Johnson & Johnson Human Reproductive Technologies Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Pfizer Inc
-
14.3.1 Pfizer Inc Company Profile
-
14.3.2 Pfizer Inc Human Reproductive Technologies Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Reckitt Benckiser Group plc
-
14.4.1 Reckitt Benckiser Group plc Company Profile
-
14.4.2 Reckitt Benckiser Group plc Human Reproductive Technologies Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 bbott Laboratories Inc
-
14.5.1 bbott Laboratories Inc Company Profile
-
14.5.2 bbott Laboratories Inc Human Reproductive Technologies Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Merck Serono
-
14.6.1 Merck Serono Company Profile
-
14.6.2 Merck Serono Human Reproductive Technologies Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Ferring International Center SA
-
14.7.1 Ferring International Center SA Company Profile
-
14.7.2 Ferring International Center SA Human Reproductive Technologies Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 Bayer AG
-
14.8.1 Bayer AG Company Profile
-
14.8.2 Bayer AG Human Reproductive Technologies Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 Church & Dwight, Co Inc
-
14.9.1 Church & Dwight, Co Inc Company Profile
-
14.9.2 Church & Dwight, Co Inc Human Reproductive Technologies Market Performance
-
14.9.3 Product&Service Introduction
-
14.10 Merck & Co Inc
-
14.10.1 Merck & Co Inc Company Profile
-
14.10.2 Merck & Co Inc Human Reproductive Technologies Market Performance
-
14.10.3 Product&Service Introduction
-
14.11 Actavis Inc
-
14.11.1 Actavis Inc Company Profile
-
14.11.2 Actavis Inc Human Reproductive Technologies Market Performance
-
14.11.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Human Reproductive Technologies Industry Research Conclusions
-
15.2 Human Reproductive Technologies Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Human Reproductive Technologies Industry Market Size (2018-2029)
-
Figure China Human Reproductive Technologies Production Volume, Production Value and Growth Rate of Zygote Intrafallopian Transfer (ZIFT) (2018-2029)
-
Figure China Human Reproductive Technologies Production Volume, Production Value and Growth Rate of In Vitro Fertilization (IVF) (2018-2029)
-
Figure China Human Reproductive Technologies Production Volume, Production Value and Growth Rate of Intracytoplasmic Sperm Injection (ICSI) (2018-2029)
-
Figure China Human Reproductive Technologies Production Volume, Production Value and Growth Rate of Intrauterine Insemination (IUI) (2018-2029)
-
Figure China Human Reproductive Technologies Production Volume, Production Value and Growth Rate of Gamete Intrafallopian Transfer (GIFT) (2018-2029)
-
Figure China Human Reproductive Technologies Production Volume, Production Value and Growth Rate of Contraceptive Technology (2018-2029)
-
Figure China Human Reproductive Technologies Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)
-
Figure China Human Reproductive Technologies Sales Volume, Sales Value and Growth Rate of Fertility Clinics (2018-2029)
-
Figure North China Human Reproductive Technologies Market Size and Growth Rate from 2018-2029
-
Figure Central China Human Reproductive Technologies Market Size and Growth Rate from 2018-2029
-
Figure South China Human Reproductive Technologies Market Size and Growth Rate from 2018-2029
-
Figure East China Human Reproductive Technologies Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Human Reproductive Technologies Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Human Reproductive Technologies Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Human Reproductive Technologies Market Size and Growth Rate from 2018-2029
-
Figure Human Reproductive Technologies Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Human Reproductive Technologies Market Share by Type in 2018
-
Figure China Human Reproductive Technologies Market Share by Type in 2023
-
Figure China Human Reproductive Technologies Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Human Reproductive Technologies Production Volume and Growth Rate of Zygote Intrafallopian Transfer (ZIFT) (2018-2023)
-
Figure China Human Reproductive Technologies Production Volume and Growth Rate of In Vitro Fertilization (IVF) (2018-2023)
-
Figure China Human Reproductive Technologies Production Volume and Growth Rate of Intracytoplasmic Sperm Injection (ICSI) (2018-2023)
-
Figure China Human Reproductive Technologies Production Volume and Growth Rate of Intrauterine Insemination (IUI) (2018-2023)
-
Figure China Human Reproductive Technologies Production Volume and Growth Rate of Gamete Intrafallopian Transfer (GIFT) (2018-2023)
-
Figure China Human Reproductive Technologies Production Volume and Growth Rate of Contraceptive Technology (2018-2023)
-
Figure China Human Reproductive Technologies Market Share by Application in 2018
-
Figure China Human Reproductive Technologies Market Share by Application in 2023
-
Figure China Human Reproductive Technologies Total Market Size and Growth Rate from Consumption End
-
Figure China Human Reproductive Technologies Market Size and Growth Rate of Hospitals (2018-2023)
-
Figure China Human Reproductive Technologies Market Size and Growth Rate of Fertility Clinics (2018-2023)
-
Table China Human Reproductive Technologies Production Volume by Region (2018-2023)
-
Table China Human Reproductive Technologies Production Volume Share by Region (2018-2023)
-
Figure China Human Reproductive Technologies Production Volume Share by Region (2018-2023)
-
Table China Human Reproductive Technologies Production Value by Region (2018-2023)
-
Table China Human Reproductive Technologies Production Value Share by Region (2018-2023)
-
Figure China Human Reproductive Technologies Production Value Share by Region (2018-2023)
-
Table China Human Reproductive Technologies Sales Volume by Region (2018-2023)
-
Table China Human Reproductive Technologies Sales Volume Share by Region (2018-2023)
-
Figure China Human Reproductive Technologies Sales Volume Share by Region (2018-2023)
-
Table China Human Reproductive Technologies Sales Value by Region (2018-2023)
-
Table China Human Reproductive Technologies Sales Value Share by Region (2018-2023)
-
Figure China Human Reproductive Technologies Sales Value Share by Region (2018-2023)
-
Table North China Human Reproductive Technologies Production Volume by Type (2018-2023)
-
Table North China Human Reproductive Technologies Production Volume Share by Type (2018-2023)
-
Figure North China Human Reproductive Technologies Production Volume Share by Type (2018-2023)
-
Table North China Human Reproductive Technologies Sales Volume by Application (2018-2023)
-
Table North China Human Reproductive Technologies Sales Volume Share by Application (2018-2023)
-
Figure North China Human Reproductive Technologies Sales Volume Share by Application (2018-2023)
-
Table Central China Human Reproductive Technologies Production Volume by Type (2018-2023)
-
Table Central China Human Reproductive Technologies Production Volume Share by Type (2018-2023)
-
Figure Central China Human Reproductive Technologies Production Volume Share by Type (2018-2023)
-
Table Central China Human Reproductive Technologies Sales Volume by Application (2018-2023)
-
Table Central China Human Reproductive Technologies Sales Volume Share by Application (2018-2023)
-
Figure Central China Human Reproductive Technologies Sales Volume Share by Application (2018-2023)
-
Table South China Human Reproductive Technologies Production Volume by Type (2018-2023)
-
Table South China Human Reproductive Technologies Production Volume Share by Type (2018-2023)
-
Figure South China Human Reproductive Technologies Production Volume Share by Type (2018-2023)
-
Table South China Human Reproductive Technologies Sales Volume by Application (2018-2023)
-
Table South China Human Reproductive Technologies Sales Volume Share by Application (2018-2023)
-
Figure South China Human Reproductive Technologies Sales Volume Share by Application (2018-2023)
-
Table East China Human Reproductive Technologies Production Volume by Type (2018-2023)
-
Table East China Human Reproductive Technologies Production Volume Share by Type (2018-2023)
-
Figure East China Human Reproductive Technologies Production Volume Share by Type (2018-2023)
-
Table East China Human Reproductive Technologies Sales Volume by Application (2018-2023)
-
Table East China Human Reproductive Technologies Sales Volume Share by Application (2018-2023)
-
Figure East China Human Reproductive Technologies Sales Volume Share by Application (2018-2023)
-
Table Northeast China Human Reproductive Technologies Production Volume by Type (2018-2023)
-
Table Northeast China Human Reproductive Technologies Production Volume Share by Type (2018-2023)
-
Figure Northeast China Human Reproductive Technologies Production Volume Share by Type (2018-2023)
-
Table Northeast China Human Reproductive Technologies Sales Volume by Application (2018-2023)
-
Table Northeast China Human Reproductive Technologies Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Human Reproductive Technologies Sales Volume Share by Application (2018-2023)
-
Table Southwest China Human Reproductive Technologies Production Volume by Type (2018-2023)
-
Table Southwest China Human Reproductive Technologies Production Volume Share by Type (2018-2023)
-
Figure Southwest China Human Reproductive Technologies Production Volume Share by Type (2018-2023)
-
Table Southwest China Human Reproductive Technologies Sales Volume by Application (2018-2023)
-
Table Southwest China Human Reproductive Technologies Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Human Reproductive Technologies Sales Volume Share by Application (2018-2023)
-
Table Northwest China Human Reproductive Technologies Production Volume by Type (2018-2023)
-
Table Northwest China Human Reproductive Technologies Production Volume Share by Type (2018-2023)
-
Figure Northwest China Human Reproductive Technologies Production Volume Share by Type (2018-2023)
-
Table Northwest China Human Reproductive Technologies Sales Volume by Application (2018-2023)
-
Table Northwest China Human Reproductive Technologies Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Human Reproductive Technologies Sales Volume Share by Application (2018-2023)
-
Table Teva Pharmaceutical Industries Ltd Company Profile
-
Table Teva Pharmaceutical Industries Ltd Human Reproductive Technologies Revenue, Price and Gross (2018-2023)
-
Table Johnson & Johnson Company Profile
-
Table Johnson & Johnson Human Reproductive Technologies Revenue, Price and Gross (2018-2023)
-
Table Pfizer Inc Company Profile
-
Table Pfizer Inc Human Reproductive Technologies Revenue, Price and Gross (2018-2023)
-
Table Reckitt Benckiser Group plc Company Profile
-
Table Reckitt Benckiser Group plc Human Reproductive Technologies Revenue, Price and Gross (2018-2023)
-
Table bbott Laboratories Inc Company Profile
-
Table bbott Laboratories Inc Human Reproductive Technologies Revenue, Price and Gross (2018-2023)
-
Table Merck Serono Company Profile
-
Table Merck Serono Human Reproductive Technologies Revenue, Price and Gross (2018-2023)
-
Table Ferring International Center SA Company Profile
-
Table Ferring International Center SA Human Reproductive Technologies Revenue, Price and Gross (2018-2023)
-
Table Bayer AG Company Profile
-
Table Bayer AG Human Reproductive Technologies Revenue, Price and Gross (2018-2023)
-
Table Church & Dwight, Co Inc Company Profile
-
Table Church & Dwight, Co Inc Human Reproductive Technologies Revenue, Price and Gross (2018-2023)
-
Table Merck & Co Inc Company Profile
-
Table Merck & Co Inc Human Reproductive Technologies Revenue, Price and Gross (2018-2023)
-
Table Actavis Inc Company Profile
-
Table Actavis Inc Human Reproductive Technologies Revenue, Price and Gross (2018-2023)
-